Recent Episodes
-
Enhancing mRNA results through strategic RNA design and quality control
Mar 27, 2025 – 12:53 -
For the many and the few: bringing ASO therapies to both mainstream and nano-rare indications
Mar 13, 2025 – 19:09 -
Exploring challenges, opportunities and state-of-the-art tools in the lipid nanoparticle space
Feb 19, 2025 – 15:03 -
Driving innovation in cell and gene therapy: the role of AI and robotics
Jan 27, 2025 – 15:38 -
Spatial mapping: shaping the future of I-O diagnostics and treatment
Dec 6, 2024 – 38:44 -
Pioneering quality control in biomanufacturing of cell and gene therapies
Dec 5, 2024 – 28:08 -
Preparing for tomorrow’s cell and gene therapies today: lessons from 30 years in the field
Sep 6, 2024 – 25:36 -
Insights into advanced therapies in the context of evolving funding and M&A environments
Jun 14, 2024 – 22:37 -
Fit for function: developing potency assays reflective of the in vivo environment
May 10, 2024 – 28:20 -
Gene therapy is having a monumental year: how can the industry keep up with supply?
Apr 4, 2024 – 23:36 -
A deep dive in to generative AI applications in I-O
Mar 18, 2024 – 43:52 -
Developing novel radioimmunotherapy combinations for lung cancer treatment
Mar 12, 2024 – 14:57 -
Focusing on the fundamentals: what do and don’t we know about mRNA delivery?
Mar 11, 2024 – 45:24 -
Navigating genomics and transcriptomics in the immuno-oncology space
Mar 1, 2024 – 20:23 -
Avian influenza and the risk of pandemic
Feb 27, 2024 – 23:38 -
Exploring the landscape of novel targets & pathways in immuno-oncology
Dec 4, 2023 – 17:05 -
Multiomics integration: advancing pediatric cancer immunotherapy
Nov 2, 2023 – 19:37 -
Building with the patient in mind: designing a state-of-the-art facility for viral vector manufacturing
Oct 10, 2023 – 28:44 -
Can AAV continue to deliver the promise of gene therapy?
Sep 13, 2023 – 21:37 -
Expanding the potential of in vivo cell therapy with tLNP-RNAs (targeted lipid nanoparticle-RNA)
Aug 30, 2023 – 20:04 -
Investing long-term in the cell & gene therapies of the future
Aug 22, 2023 – 15:25 -
Happy medium: considerations in scaling cell culture media strategies
Aug 16, 2023 – 19:11 -
Applying multiomics to novel target discovery in immuno-oncology
Aug 8, 2023 – 18:42 -
Modernizing cell therapy manufacturing to reduce vein-to-vein times
Jul 26, 2023 – 23:49 -
Inducing innate immune responses with particulate adjuvants
Jul 26, 2023 – 13:38 -
Navigating the complexities of biodistribution, transgene expression & vector shedding in gene therapy development
Jun 9, 2023 – 31:06 -
Non-viral methods for ex vivo cell & gene therapy: is the future non-viral?
May 31, 2023 – 21:37 -
Solving challenges in cell therapy clinical trials & effectively delivering complex studies in advanced therapeutics
Apr 17, 2023 – 25:00 -
Shear ignorance? Think again: breaking the perception of shear within viral vector manufacturing
Apr 6, 2023 – 18:05 -
Challenges in cryogenic storage containers for cell and gene therapy
Mar 22, 2023 – 17:48 -
Maximizing Efficiency and Flexibility in Viral Vector Manufacturing Scale-up
Mar 2, 2023 – 37:09 -
Improvement of viral vector purification using Mustang Q membrane chromatography
Dec 13, 2022 – 32:25 -
Shear ignorance? Think again: breaking the perception of shear within viral vector manufacturing
Nov 9, 2022 – 18:05 -
CAR-T cells: from cancer to autoimmunity
Oct 12, 2022 – 30:02 -
Tales, tips & teachable moments from applications support veterans
Oct 11, 2022 – 25:21 -
Access to vaccines: how can we leverage technology innovations to achieve greater vaccine equity?
Sep 30, 2022 – 18:36 -
De-risk & accelerate the drug development process for gene therapy
Sep 29, 2022 – 11:31 -
Working Together to Safely Advance Cell & Gene Therapies
Sep 27, 2022 – 01:00:00 -
Learning from pediatric CAR-T development: insights from manufacturing unique patient doses
Sep 26, 2022 – 20:55 -
Insights into the editing of the human genome: where can novel non-viral polymeric delivery agents take us
Sep 12, 2022 – 28:11 -
Making the switch from autologous to allogeneic cell therapy
Sep 9, 2022 – 27:55 -
Accelerating cures: funding stem cell innovation & ideas in an evolving cell therapy space
Sep 5, 2022 – 15:52 -
Insights into the editing of the human genome: where can novel non-viral polymeric delivery agents take us
Aug 16, 2022 – 28:11 -
Achieving better AAV vector productivity and product quality
Aug 5, 2022 – 18:59 -
Partnering in life sciences: what is the ‘secret sauce’ for success? PART 2
Jul 25, 2022 – 19:33 -
Partnering in life sciences: what is the secret sauce for success? PART 1: The Big Pharma perspective
Jul 18, 2022 – 28:33 -
Where will tomorrow’s workforce come from? PART 4: Who are tomorrow’s cell and gene therapy workers?
Jun 20, 2022 – 44:59 -
Where will tomorrow’s workforce come from? PART 3: Innovation in staff sourcing, training and retention - what works and what doesn’t?
Jun 20, 2022 – 26:01 -
Where will tomorrow’s workforce come from? PART 2: How is the educational system responding, and how can the cell and gene therapy community at large help?
Jun 7, 2022 – 32:30 -
Where will tomorrow’s workforce come from? PART1: Framing the issue
Jun 7, 2022 – 28:45
Recent Reviews
Similar Podcasts
Disclaimer: The podcast and artwork on this page are property of the podcast owner, and not endorsed by UP.audio.